Roche Diagnostics sees sales acceleration in second half
This article was originally published in Clinica
Executive Summary
Roche Diagnostics expects an acceleration in its sales growth from the middle of 2005, as it rolls out a new blood glucose monitor and insulin pump for diabetics in Europe. The Accu-Chek Aviva test is already available in the Netherlands and Scandinavia, while the Accu-Chek Spirit pump has been launched in Germany and the Netherlands.